PMDA consults on three candidates for the Japanese Pharmacopoeia
The candidates include a carbamazepine preparation; comments on possible future inclusion closed on 18 October 2026.
PMDA published three candidate monographs for possible future inclusion in the 19th Japanese Pharmacopoeia, including a carbamazepine preparation. The consultation deadline was 18 October 2026.
These are candidates, not effective monographs. Laboratories should distinguish the proposal from adopted requirements and consult the final official text if a monograph is later approved.